4-hydroxy-2-nonenal has been researched along with Brain-Diseases* in 2 studies
1 review(s) available for 4-hydroxy-2-nonenal and Brain-Diseases
Article | Year |
---|---|
Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly.
Phospholipase A2 (PLA2) generates arachidonic acid, docosahexaenoic acid, and lysophospholipids from neural membrane phospholipids. These metabolites have a variety of physiological effects by themselves and also are substrates for the synthesis of more potent lipid mediators such as eicosanoids, platelet activating factor, and 4-hydroxynonenal (4-HNE). At low concentrations, these mediators act as second messengers. They affect and modulate several cell functions, including signal transduction, gene expression, and cell proliferation, but at high concentrations, these lipid mediators cause neurotoxicity. Among the metabolites generated by PLA2, 4-HNE is the most cytotoxic metabolite and is associated with the apoptotic type of neural cell death. Levels of 4-HNE are markedly increased in neurological disorders such as Alzheimer disease, Parkinson disease, ischemia, spinal cord trauma, and head injury. The purpose of this review is to summarize and integrate the vast literature on metabolites generated by PLA2 for a wider audience. The authors hope that this discussion will jump-start more studies not only on the involvement of PLA2 in neurological disorders but also on the importance of PLA2-generated lipid mediators in physiological and pathological processes. Topics: Aldehydes; Animals; Brain; Brain Diseases; Cytotoxins; Eicosanoids; Humans; Membrane Lipids; Nerve Degeneration; Neurons; Phospholipases A; Phospholipases A2; Phospholipids | 2006 |
1 other study(ies) available for 4-hydroxy-2-nonenal and Brain-Diseases
Article | Year |
---|---|
Evidence of oxidative injury of the spinal cord in 2 horses with equine degenerative myeloencephalopathy.
The cervical spinal cords of 2 horses with equine degenerative myeloencephalopathy (EDM) were evaluated for evidence of oxidative damage to the central nervous system (CNS) using immunohistochemical staining for 3-nitrotyrosine (3-NT) and 4-hydroxynonenol (4-HNE). Neurons of the CNS from horses with EDM had positive immunohistochemical staining, whereas control samples did not, thus supporting the theory that oxidative damage is a potential underlying factor in horses with EDM. In addition, serum vitamin E concentration was low in both EDM-affected horses, and vitamin E concentration was also deficient in the cerebrospinal fluid in 1 EDM horse, further supporting the association between low vitamin E concentrations and oxidative damage to the CNS. Continued research is necessary to further define the pathophysiologic mechanisms of EDM. Topics: Aldehydes; Animals; Ataxia; Brain Diseases; Central Nervous System; Female; Horse Diseases; Horses; Immunohistochemistry; Neurodegenerative Diseases; Oxidative Stress; Spinal Cord Diseases; Tyrosine; Vitamin E; Vitamin E Deficiency | 2012 |